PharmEasy Unlisted Share

Pharmeasy’s Product Offerings & Value Chain

API Holdings Ltd aka Pharmeasy is India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report.

Pharmeasy operate an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages -

A. providing digital tools and information on illness and wellness,

B. offering teleconsultation,

C. offering diagnostics and radiology tests, and

D. delivering treatment protocols including products and devices.

Pharmeasy has custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us. These capabilities enable us to provide each stakeholder in the healthcare value-chain, viz.:

(a) channel (wholesalers, retailers and chemists/institutions),

(b) consultants (and hospitals), diagnostic and radiology labs,

(c) consumers, and

(d) companies (pharmaceutical, nutraceutical, medical devices)

with the technology tools and capabilities to solve their challenges, while also enabling them to benefit from an interconnected network.

Pharmeasy’s Distribution & Presence

Pharmeasy’s businesses have a presence across the country, with last-mile to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing them the ability to provide access in an affordable manner.

The Company’s audited standalone and consolidated financial performance for the financial
year ended March 31, 2022 is summarised below

The financial statements of the Company for the financial year 2021-22 are prepared in accordance with Indian Accounting Standards (“Ind AS”), notified under Section 133 of the Companies Act, 2013, (“the Act”) read with the Companies (Accounts) Rules, 2014.

Pharmeasy’s Holistic Presence across the Healtcare Value Chain

Multiple use cases across a consumer’s healthcare journey

Major events in the history of API Holdings Limited (Pharmeasy)

2022

Acquisition of 71.22% of the paid-up equity share capital of Thyrocare Technologies Private Limited

• Investment by Internet Fund VI Pte. Ltd.
• Acquisition of 67.30% of the paid-up equity share capital of Akna Medical Private Limited
• Acquisition of 49.17% of the paid-up equity share capital of Marg ERP Limited
• Investment by Naspers Ventures B.V., TPG Growth V SF Markets Pte. Ltd., Macritchie Investments Pte. Ltd. and B Capital Asia II, Ltd, B Capital GF III CI Holdco III LLC, B Capital GF III CI (B) Holdco III LLC in our Company

2021

• Acquisition of of Medlife International Private Limited
• Investment by Nasper Ventures B.V. and TPG Growth V SF Markets Pte. Ltd
• Launch of video consultation offering on DocOn platform

2020

• Launch of sale of private label products under the brand ‘LivEasy’
• Investment by Bessemer India Capital Holdings II Ltd., CDPQ Private Equity Asia Pte. Ltd., The Fundamentum Partnership Fund I, Eight Roads India Ventures III L.P., F-Prime Capital Partners Healthcare Fund V LP, TIMF Holdings, Financial Investments SPC, KB Global Platform Fund Limited, MacRitchie Investments Pte. Ltd. and Orios Advisors LLP in 91Streets Media Technologies Private Limited
• Acquisition of ERP and customer relationship management software ‘RedBook.

For a complete overview on API Holdings Ltd (Pharmeasy read our comprehensive blog here : https://altiusinvestech.com/blog/api-holdings-pharmeasy-listing-price-justified/

Marquee Investors of Pharmeasy (API Holdings Ltd)

• Naspers Ventures BV
• Macritchie Investments Pte Ltd
• TP G Growth V SF Markets Pvt Ltd

IPO Updates

API Holdings, the parent company of online pharmacy start-up PharmEasy, on Monday received approval from Sebi to raise Rs 6,250 crore through an initial public offering (IPO).

Pharmeasy was last valued at $5.6 billion (Rs 42,197.79 crore) in a Rs 2,635.22-crore pre-IPO round in October 21.

Key Highlights

On 29 November 2021 API Holding Limited issue equity shares of FV Rs 1 per shares @ 4.20 per shares (Details are given below)

CCPS B Issue

PharmEasy Consolidated Annual Report 2023

PharmEasy Annual Report 2021 

PharmEasy Standalone Annual Report 2022

PharmEasy Consolidate Annual Report 2022